PGR and breast carcinoma: Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (Figure 3) demonstrated the mechanistic applications of breast cancer-like organs.